COVAXIN na Indiya, maganin COVID-19 wanda Bharat Biotech ke samarwa na asali ne daga hukumomin Ostiraliya don yin balaguro. covaxin an riga an amince da shi a wasu ƙasashe tara. Koyaya, har yanzu ana jiran amincewar WHO.
Abin sha'awa, kusan dukkanin allurar rigakafin COVID-19 da aka amince da su a halin yanzu a cikin duniya ko dai maganin mRNA ne ko kuma rigakafin halittar adenovirus vector DNA wanda ya dogara da dabaru da fasahohin da ba a taɓa amfani da su akan ɗan adam a baya ba.
Covaxin, a daya bangaren, alluran rigakafin da ba a yi amfani da su ba ne bisa ga gwajin fasahar kere kere na al'ada na zamani wanda ya yi tsayin daka fiye da rabin karni kuma ya taka muhimmiyar rawa wajen sarrafawa da kawar da cututtuka masu yawa.
Amincewa da Covaxin ta WHO yana ci gaba. A fili, Ƙungiyar Ba da Shawarwari ta Fasaha don Lissafin Amfani da Gaggawa (TAG-EUL) ya nemi ƙarin bayani daga masana'anta. Kamar yadda bayanin da ake samu akan gidan yanar gizon game da Matsayin rigakafin COVID-19 a cikin WHO EUL/Tsarin kimantawa na farko, ana ci gaba da tantancewar kamar ranar 20 ga Oktoba 2021.
An yi imanin cewa amincewar WHO na Covaxin zai taimaka wa ƙasashe da yawa a Asiya da Afirka.
***
